Filing Details
- Accession Number:
- 0001127602-18-017517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-15 16:09:06
- Reporting Period:
- 2018-05-14
- Accepted Time:
- 2018-05-15 16:09:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221496 | George Massaro | 251 Ballardvale Street Wilmington MA 01887 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-14 | 2,004 | $0.00 | 15,055 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $106.05 | 14,955 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $106.45 | 14,855 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $106.85 | 14,755 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.08 | 14,655 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 118 | $107.10 | 14,537 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.14 | 14,437 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.48 | 14,337 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.55 | 14,237 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 200 | $107.62 | 14,037 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.67 | 13,937 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-14 | 100 | $107.69 | 13,837 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders.
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
